Viewing molecular mechanisms of ageing through a lens

Age-related Eye Disease Study, 2001. Risk factors associated with age-related nuclear and cortical cataract. Ophthalmol. 108, 1400–1408.

Anthony, 2000, Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists, Neurology, 54, 2066, 10.1212/WNL.54.11.2066

Antiplatelet Triallists’ Collaboration, 1988. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br. Med. J. 296, 320–331.

Bax, 1990, X-ray analysis of βB2-crystallin and evolution of the oligomeric lens proteins, Nature, 347, 776, 10.1038/347776a0

Beswick, 1987, Conformational changes induced in lens α- and γ- crystallins by modification with glucose 6-phosphate. Implications for cataract, Biochem. J., 246, 761, 10.1042/bj2460761

Blakytny, 1992, Prevention of cataract in diabetic rats by aspirin, paracetamol (acetaminophen) and ibuprofen, Exp. Eye Res., 54, 509, 10.1016/0014-4835(92)90129-G

Brion, 1991, Tau in Alzheimer neurofibrillary tangles, Biochem. J., 273, 127, 10.1042/bj2730127

Carrell, 1997, Conformational disease, Lancet, 350, 134, 10.1016/S0140-6736(97)02073-4

Cerami, 1987, Glucose and ageing, Sci. Am., 255, 90, 10.1038/scientificamerican0587-90

Christen, 1998, Low-dose aspirin and risk of cataract and subtypes in a randomised trial of US physicians, Ophthal. Epidemiol., 5, 133, 10.1076/opep.5.3.133.8368

Clark, 1987, Phase separation in lens cytoplasm is genetically linked to cataract formation in the Philly mouse, Proc. Natl. Acad. Sci. U.S.A., 84, 122, 10.1073/pnas.84.1.122

Derham, 1999, α-Crystallin as a molecular chaperone, Prog. Retinal Eye Res., 18, 463, 10.1016/S1350-9462(98)00030-5

Diener, 1999, Aspirin in the prevention of strokes, Biomed. Pharmacother., 53, 309, 10.1016/S0753-3322(00)88501-7

Farahbakhsh, 1995, Interaction of α-crystallin with spin-labelled peptides, Biochemistry, 34, 509, 10.1021/bi00002a015

Finch, 1997, Aging, Metabolism and Alzheimer disease: review and hypotheses, Exp. Neurol., 143, 82, 10.1006/exnr.1996.6339

Ganea, 1995, Molecular chaperones protect against glycation-induced inactivation of glucose 6-phosphate dehydrogenase, Eur. J. Biochem., 231, 181, 10.1111/j.1432-1033.1995.tb20684.x

Ganea, 1996, Inhibition of 6-phosphogluconate dehydrogenase by carbamylation and protection by α-crystallin, a chaperone-like protein, Biochem. Biophys. Res. Commun., 222, 626, 10.1006/bbrc.1996.0794

Haley, 1998, The small heat-shock protein, αB-crystallin, has a variable quaternary structure, J. Mol. Biol., 277, 27, 10.1006/jmbi.1997.1611

Harding, 1972, Conformational changes in human lens proteins in cataract, Biochem. J., 129, 97, 10.1042/bj1290097

Harding, 1985, Nonenzymatic posttranslational modification of proteins in vivo, Adv. Protein Chem., 37, 247, 10.1016/S0065-3233(08)60066-2

Harding, J.J., 1991. Cataract: Biochemistry, Epidemiology and Pharmacology. Chapman & Hall, London.

Harding, 1993, Pathophysiology of cataract, Curr. Opin. Ophthalmol., 4, 14, 10.1097/00055735-199302000-00004

Harding, 1994, Estrogens and cataract, Arch. Ophthalmol., 112, 1511, 10.1001/archopht.1994.01090240017008

Harding, 2001, Can drugs or micronutrients prevent cataract?, Drugs Ageing, 18, 473, 10.2165/00002512-200118070-00001

Harding, 1989, Protection against cataract by aspirin, paracetamol and ibuprofen, Acta Ophthalmol., 67, 518, 10.1111/j.1755-3768.1989.tb04102.x

Heath, 1996, Glycation-induced inactivation of malate dehydrogenase: protection by aspirin and a lens molecular chaperone, alpha-crystallin, Biochim. Biophys. Acta, 1315, 176, 10.1016/0925-4439(95)00120-4

Hook, 1996, Alpha-crystallin acting as a molecular chaperone protects catalase against steroid-induced inactivation, FEBS Lett., 382, 281, 10.1016/0014-5793(96)00134-2

Hook, 1998, Protection of enzymes by α-crystallin acting as a molecular chaperone, Int. J. Biol. Macromol., 22, 295, 10.1016/S0141-8130(98)00027-0

Jacob, 1968, Abnormal haem binding and globin SH group blockade in unstable haemoglobins, Nature, 218, 1214, 10.1038/2181214a0

Janne, 2000, Chemoprevention of colorectal cancer, New Engl. J. Med., 342, 1960, 10.1056/NEJM200006293422606

Kawas, 1997, A prospective study of estrogen replacement therapy and the risk of developing Alzheimer’s disease: the Baltimore longitudinal study of aging, Neurology, 48, 1517, 10.1212/WNL.48.6.1517

Klein, 1994, Is there evidence of an estrogen effect on age-related lens opacities?, Arch. Ophthalmol., 112, 85, 10.1001/archopht.1994.01090130095025

Klein, 2001, Drug use and five-year incidence of age-related cataracts, Ophthalmology, 108, 1670, 10.1016/S0161-6420(01)00656-X

Levi, 2001, A review of cancer chemopreventive agents, Curr. Med. Chem., 8, 1349, 10.2174/0929867013372229

Lindner, 2001, The molecular chaperone α-crystallin is in kinetic competition with aggregation to stabilise a monomeric molten-globule form of α-lactalbumin, Biochem. J., 354, 79, 10.1042/0264-6021:3540079

Minassian, 1990, 3.8 Million blinded by cataract each year: projections from the first epidemiological study of incidence of cataract blindness in India, Brit. J. Ophthalmol., 74, 341, 10.1136/bjo.74.6.341

Mohan, 1989, India-US case-control study of age-related cataracts, Arch. Ophthalmol., 107, 670, 10.1001/archopht.1989.01070010688028

Nelson, 2000, Inverse association of prostate cancer and non-steroidal anti-inflammatory drugs (NSAIDs): results of a case-control study, Oncol. Rep., 7, 169

Paterson, 2001, Salicylic acid: a link between aspirin, diet and the prevention of colorectal cancer, Q. J. Med., 94, 445, 10.1093/qjmed/94.8.445

Raza, 1991, Non-enzymic modification of lens proteins by glucose and fructose: effects of ibuprofen, Exp. Eye Res., 52, 205, 10.1016/0014-4835(91)90260-L

Rigas, 2000, Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradiction, Med. Hypotheses, 54, 210, 10.1054/mehy.1999.0023

Robinson, 1974, Deamidation of glutaminyl and asparaginyl residues in peptides and proteins, Curr. Top. Cell Regulation, 8, 247, 10.1016/B978-0-12-152808-9.50013-4

Sohrabji, 1997, Hormone replacement: therapeutic strategies in the treatment of Alzheimer’s disease and ageing-related cognitive disorders, Expert Opin. Ther. Pat., 7, 611, 10.1517/13543776.7.6.611

Stevens, 1978, Diabetic cataract formation: potential role of glycosylation of lens crystallins, Proc. Natl. Acad. Sci. U.S.A., 75, 2918, 10.1073/pnas.75.6.2918

Swamy, 1989, Inhibition of lens crystallin glycation and high molecular weight aggregate formation by aspirin in vitro and in vivo, Invest. Ophthalmol. Vis. Sci., 30, 1120

van Heyningen, Harding, J.J., 1986. Do aspirin-like analgesics protect against cataract? Lancet 1, 1111–1113.

Vicart, 1998, A missense mutation in the αB-crystallin gene causes a desmin-related myopathy, Nat. Genet., 20, 92, 10.1038/1765

Vitek, 1994, Advanced glycation endproducts contribute to amyloidosis in Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A., 91, 4766, 10.1073/pnas.91.11.4766

Wang, 1996, Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer’s disease, Nat. Med., 2, 871, 10.1038/nm0896-871

West, 1987, Lack of evidence for aspirin use and prevention of cataracts, Arch. Ophthalmol., 105, 1229, 10.1001/archopht.1987.01060090087034

Wistow, 1983, X-ray analysis of the eye lens protein γII-crystallin at 1.9 A resolution, J. Mol. Biol., 170, 175, 10.1016/S0022-2836(83)80232-0

Yan, 1994, Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress, Proc. Natl. Acad. Sci. U.S.A., 91, 7787, 10.1073/pnas.91.16.7787

Zhou, 2001, Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak, Carcinogenesis, 22, 1393, 10.1093/carcin/22.9.1393